Patent details

EP2536727 Title: DEUTERATED PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6

Basic Information

Publication number:
EP2536727
PCT Application Number:
PCT/EP/2011/052365
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117042259
PCT Publication Number:
WO/2011/101417
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DEUTERATED PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6
French Title of Invention:
COMPOSÉS DEUTÉRIÉS DE LA PYRROLOPYRIMIDINE UTILISÉS EN TANT QU'INHIBITEURS DES CDK4/6
German Title of Invention:
DEUTERIERTE PYRROLOPYRIMIDIN VERBINDUNGEN ALS CDK4/6 INHIBITOREN
SPC Number:

Dates

Filing date:
17/02/2011
Grant date:
02/07/2014
EP Publication Date:
02/07/2014
PCT Publication Date:
25/08/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/12/2012
EP B1 Publication Date:
02/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/02/2015
Expiration date:
17/02/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/02/2011
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
PEREZ Lawrence Blas
Address:
United States (US)

2

Name:
BRAIN Christopher Thomas
Address:
United States (US)

Priority

Priority Number:
306248 P
Priority Date:
19/02/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 487/04;
Filing date Document type Number of pages